John H. Johnson's most recent trade in Xeris Biopharma Holdings Inc was a trade of 135,400 Common Stock done at an average price of $7.2 . Disclosure was reported to the exchange on Dec. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 19 Dec 2025 | 135,400 | 698,083 (2%) | 0% | 7.2 | 977,019 | Common Stock |
| Axogen Inc | John H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 29.98 per share. | 08 Dec 2025 | 13,141 | 0 (0%) | 0% | 30.0 | 393,993 | Common Stock |
| Axogen Inc | John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 11,891 | 8,545 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | John H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 31.22 per share. | 08 Dec 2025 | 11,891 | 13,141 (0%) | 0% | 31.2 | 371,273 | Common Stock |
| Axogen Inc | John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. | 08 Dec 2025 | 11,891 | 25,032 (0%) | 0% | 6.3 | 74,913 | Common Stock |
| Axogen Inc | John H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 31.26 per share. | 08 Dec 2025 | 11,802 | 13,141 (0%) | 0% | 31.3 | 368,931 | Common Stock |
| Axogen Inc | John H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 29.98 per share. | 08 Dec 2025 | 8,545 | 13,141 (0%) | 0% | 30.0 | 256,196 | Common Stock |
| Axogen Inc | John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. | 08 Dec 2025 | 8,545 | 21,686 (0%) | 0% | 6.3 | 53,834 | Common Stock |
| Axogen Inc | John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 8,545 | 0 | - | - | Stock Option (right to purchase) | |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 1023.26 per share. | 17 Nov 2025 | 215 | 3,264 (0%) | 0% | 1023.3 | 220,000 | Common Stock |
| Flowserve Corp | Cheryl H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2025 | 435 | 10,888 | - | - | Phantom Stock | |
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 7.32 per share. | 13 Aug 2025 | 107,500 | 833,483 (3%) | 0% | 7.3 | 786,459 | Common Stock |
| Universal Corp | Thomas H Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 2,290 | 32,619 (0%) | 0% | 0 | Common Stock | |
| Flowserve Corp | Cheryl H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2025 | 540 | 10,453 | - | - | Phantom Stock | |
| Lifecore Biomedical Inc | Paul H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 19,506 | 44,060 (0%) | 0% | - | Common Stock | |
| SPX Tech Inc | Johnson H. Cheree | VP, CLO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 167.68 per share. | 01 Jul 2025 | 396 | 7,147 (0%) | 0% | 167.7 | 66,401 | Common Stock |
| Kentucky First Federal Bancorp | William H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 2.85 per share. | 27 Jun 2025 | 3,597 | 45,848 (0%) | 0% | 2.8 | 10,251 | Common Stock |
| Axogen Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2025 | 14,150 | 14,150 | - | - | Restricted Stock Units | |
| Axogen Inc | John H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 09 Jun 2025 | 4,073 | 24,943 (0%) | 0% | 10.6 | 43,215 | Common Stock |
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 50,000 | 940,983 (3%) | 0% | 0 | Common Stock | |
| Ameresco Inc (Class A) | Claire D'Oyly-Hughes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 10,435 | 10,435 | - | - | Restricted Stock Unit | |
| Ameresco Inc (Class A) | Claire D'Oyly-Hughes Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 4,886 | 0 | - | - | Restricted Stock Unit | |
| Ameresco Inc (Class A) | Claire D'Oyly-Hughes Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 4,886 | 10,111 (0%) | 0% | 0 | Class A Common Stock | |
| HubSpot Inc | Claire D'Oyly-Hughes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 400 | 1,628 (0%) | 0% | 0 | Common Stock | |
| Aspen Aerogels Inc | Virginia H. Johnson | CLO, GC, and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.39 per share. | 23 May 2025 | 6,129 | 44,450 (0%) | 0% | 6.4 | 39,164 | Common Stock |
| Aurora Innovation Inc (Class A) | Claire D'Oyly-Hughes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 31,875 | 360,559 | - | 0 | Class A Common Stock | |
| Verastem Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Verastem Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 8,333 | 16,666 (0%) | 0% | 0 | Common Stock | |
| Flowserve Corp | Cheryl H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 3,099 | 9,913 | - | - | Phantom Stock | |
| Flowserve Corp | Cheryl H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 639 | 6,814 | - | - | Phantom Stock | |
| Aspen Aerogels Inc | Virginia Johnson H. | CLO, GC, and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.95 per share. | 07 Mar 2025 | 1,924 | 50,579 (0%) | 0% | 8.0 | 15,296 | Common Stock |
| Aspen Aerogels Inc | Virginia Johnson H. | CLO, GC, Secretary & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 52,614 | 52,614 | - | - | Performance Share Units | |
| Aspen Aerogels Inc | Virginia Johnson H. | CLO, GC, Secretary & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 37,804 | 37,804 | - | - | Stock Options (Right to Buy) | |
| Aspen Aerogels Inc | Virginia Johnson H. | CLO, GC, Secretary & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 26,307 | 52,503 (0%) | 0% | 0 | Common Stock | |
| Aspen Aerogels Inc | Virginia Johnson H. | CLO, GC, Secretary & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.84 per share. | 05 Mar 2025 | 936 | 26,196 (0%) | 0% | 7.8 | 7,338 | Common Stock |
| Ameresco Inc (Class A) | Claire D'Oyly-Hughes Johnson | Director | Purchase of securities on an exchange or from another person at price $ 9.95 per share. | 04 Mar 2025 | 1,800 | 1,800 (0%) | 0% | 10.0 | 17,910 | Class A Common Stock |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 325.30 per share. | 04 Mar 2025 | 232 | 15,255 (0%) | 0% | 325.3 | 75,470 | Common Stock |
| SPX Tech Inc | Cheree H. Johnson | VP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,414 | 7,543 (0%) | 0% | - | Common Stock | |
| SPX Tech Inc | Cheree H. Johnson | VP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 2,576 | 2,576 | - | - | Employee stock option to purchase common stock | |
| Flowserve Corp | Cheryl H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 549 | 6,175 | - | - | Phantom Stock | |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 3,345 | 16,354 (0%) | 0% | 0 | Common Stock | |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 362.70 per share. | 11 Feb 2025 | 919 | 15,435 (0%) | 0% | 362.7 | 333,321 | Common Stock |
| Marinus Pharmaceuticals Inc | Marvin H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 21 Jan 2025 | 1,610 | 12,490 (0%) | 0% | 0.5 | 869 | Common Stock |
| Kentucky First Federal Bancorp | William H. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 2.98 per share. | 23 Dec 2024 | 10,000 | 49,445 (0%) | 0% | 3.0 | 29,800 | Common Stock |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 805.58 per share. | 16 Dec 2024 | 12 | 3,032 (0%) | 0% | 805.6 | 9,667 | Common Stock |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 3,015 (0%) | 0% | 728.5 | 220,000 | Common Stock |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 743.62 per share. | 18 Nov 2024 | 13 | 2,712 (0%) | 0% | 743.6 | 9,667 | Common Stock |
| Flowserve Corp | Cheryl H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 509 | 5,626 | - | - | Phantom Stock | |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 378.84 per share. | 04 Nov 2024 | 2,664 | 12,951 (0%) | 0% | 378.8 | 1,009,230 | Common Stock |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 906.09 per share. | 21 Oct 2024 | 11 | 2,699 (0%) | 0% | 906.1 | 9,967 | Common Stock |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 923.50 per share. | 16 Sep 2024 | 10 | 2,688 (0%) | 0% | 923.5 | 9,235 | Common Stock |
| Axogen Inc | John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 29,016 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 0 | - | - | Restricted Stock Units | |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 342.48 per share. | 22 Aug 2024 | 2,975 | 15,615 (0%) | 0% | 342.5 | 1,018,878 | Common Stock |
| Lifecore Biomedical Inc | Paul H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 24,554 | 24,554 (0%) | 0% | - | Common Stock | |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 921.80 per share. | 19 Aug 2024 | 10 | 2,674 (0%) | 0% | 921.8 | 9,218 | Common Stock |
| Universal Corp | Thomas H Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 2,660 | 30,164 (0%) | 0% | 0 | Common Stock | |
| Flowserve Corp | Cheryl H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 615 | 5,117 | - | - | Phantom Stock | |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 16 Jul 2024 | 1,508 | 18,515 (0%) | 0% | 350 | 527,800 | Common Stock |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 950.50 per share. | 15 Jul 2024 | 10 | 2,664 (0%) | 0% | 950.5 | 9,505 | Common Stock |
| Verastem Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Marinus Pharmaceuticals Inc | Marvin H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 10,450 | 10,450 | - | - | Stock Option (Right to Buy) | |
| Verastem Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 8,333 | 8,333 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Marvin H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 2,300 | 14,100 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 885.00 per share. | 17 Jun 2024 | 11 | 2,654 (0%) | 0% | 885 | 9,735 | Common Stock |
| Trevena Inc | Marvin H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 13,700 | 13,700 | - | - | Stock Option (Right to Buy) | |
| Ameresco Inc (Class A) | Claire Hughes Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 3,062 | 0 | - | - | Restricted Stock Unit | |
| Ameresco Inc (Class A) | Claire Hughes Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 3,062 | 5,225 (0%) | 0% | 0 | Class A Common Stock | |
| HubSpot Inc | Claire Hughes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 412 | 1,228 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 18,248 | 18,248 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 10,653 | 17,112 (0%) | 0% | - | Common Stock | |
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 890,983 (3%) | 0% | 0 | Common Stock | |
| Ameresco Inc (Class A) | Claire Hughes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,886 | 4,886 | - | - | Restricted Stock Unit | |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 340.00 per share. | 30 May 2024 | 1,508 | 20,023 (0%) | 0% | 340 | 512,720 | Common Stock |
| Aurora Innovation Inc (Class A) | Claire Hughes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 74,075 | 328,684 | - | 0 | Class A Common Stock | |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 783.17 per share. | 20 May 2024 | 12 | 2,639 (0%) | 0% | 783.2 | 9,398 | Common Stock |
| Flowserve Corp | Cheryl H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 3,210 | 4,502 | - | - | Phantom Stock | |
| Flowserve Corp | Cheryl H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 610 | 1,292 | - | - | Phantom Stock | |
| NeoVolta Inc | Henry Ardes Johnson | CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 1,280,000 | 1,280,000 | - | - | Restricted Stock Units | |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 750.77 per share. | 15 Apr 2024 | 13 | 2,627 (0%) | 0% | 750.8 | 9,760 | Common Stock |
| Kentucky First Federal Bancorp | William H. Johnson | Director, Vice President | 02 Apr 2024 | 1,700 | 39,445 (0%) | 0% | 3.9 | 6,681 | Common Stock | |
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.99 per share. | 18 Mar 2024 | 215,600 | 751,412 (2%) | 0% | 2.0 | 429,044 | Common Stock |
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 215,600 | 0 | - | - | Stock Option (Right to Buy) | |
| Eli Lilly | Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 762.69 per share. | 18 Mar 2024 | 13 | 2,614 (0%) | 0% | 762.7 | 9,915 | Common Stock |
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Other type of transaction at price $ 0.00 per share. | 15 Mar 2024 | 89,571 | 840,983 (3%) | 0% | - | Common Stock | |
| Verastem Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 8,549 | 8,549 | - | - | Stock Option (right to buy) | |
| Verastem Inc | John H. Johnson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 2,300 | 0 | - | - | Stock Option (right to buy) | |
| Verastem Inc | John H. Johnson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 2,083 | 0 | - | - | Stock Option (right to buy) | |
| Verastem Inc | John H. Johnson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 2,083 | 0 | - | - | Stock Option (right to buy) | |
| Verastem Inc | John H. Johnson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 2,083 | 0 | - | - | Stock Option (right to buy) | |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 5,994 | 5,994 | - | - | Employee Stock Options | |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,846 | 21,452 (0%) | 0% | 0 | Common Stock | |
| Flowserve Corp | Cheryl Johnson H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 682 | 682 | - | - | Phantom Stock | |
| Eli Lilly | Johnson H. Kimberly | Director | Grant, award, or other acquisition of securities at price $ 755.69 per share. | 20 Feb 2024 | 13 | 2,597 (0%) | 0% | 755.7 | 9,824 | Common Stock |
| Caterpillar | Cheryl H. Johnson | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 4,213 | 20,737 (0%) | 0% | 0 | Common Stock | |
| Caterpillar | Johnson H. Cheryl | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.40 per share. | 13 Feb 2024 | 1,197 | 19,540 (0%) | 0% | 313.4 | 375,140 | Common Stock |
| Marinus Pharmaceuticals Inc | Johnson Marvin H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | H. Johnson Marvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 4,600 | 11,800 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | H. Kimberly Johnson | Director | Grant, award, or other acquisition of securities at price $ 634.60 per share. | 16 Jan 2024 | 15 | 2,584 (0%) | 0% | 634.6 | 9,519 | Common Stock |
| Yum China Holdings Inc | Huang Johnson | Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2023 | 25 | 8,124 | - | - | Restricted Stock Unit | |
| Yum China Holdings Inc | Huang Johnson | Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2023 | 12 | 4,055 | - | - | Restricted Stock Unit |